Thomas Mercher
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 22
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 5
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 11
- RNA modifications and cancer 9
- Cancer-related gene regulation 5
- Protein Degradation and Inhibitors 5
- Immunology top 5%
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- D. Gary GillilandRoss L. LevineGerlinde WernigBenjamin H. LeeOlivier BernardSandra MooreRachel OkabeBenjamin L. Ebert
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Thomas Mercher
52 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Genetics 1.9k
- Hematology 2.0k
- Rheumatology 683
- Molecular Biology 2.4k
- Immunology 482
Countries citing papers authored by Thomas Mercher
This map shows the geographic impact of Thomas Mercher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mercher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mercher more than expected).
Fields of papers citing papers by Thomas Mercher
This network shows the impact of papers produced by Thomas Mercher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mercher. The network helps show where Thomas Mercher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Mercher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 9 | |
| 3 | 2021 | 0 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 10 | |
| 6 | 2018 | 15 | |
| 7 | 2017 | 14 | |
| 8 | 2013 | 387 | |
| 9 | 2013 | 48 | |
| 10 | 2013 | 121 | |
| 11 | 2012 | 26 | |
| 12 | 2012 | 22 | |
| 13 | 2012 | 3 | |
| 14 | 2010 | 13 | |
| 15 | 2010 | 285 | |
| 16 | 2009 | 73 | |
| 17 | MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasiabreakdown → | 2006 | 1024 |
| 18 | 2005 | 74 | |
| 19 | 2001 | 43 | |
| 20 | 2001 | 174 |
About Thomas Mercher
Thomas Mercher is a scholar working on Hematology, Genetics and Aging, having authored 53 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Cancer-related gene regulation (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Genetics (1.9k citations), Hematology (2.0k citations) and Rheumatology (683 citations). Thomas Mercher has collaborated with scholars based in France, United States and Germany. Frequent co-authors include D. Gary Gilliland, Ross L. Levine, Gerlinde Wernig, Benjamin H. Lee, Olivier Bernard, Sandra Moore, Rachel Okabe, Benjamin L. Ebert, Yana Pikman and Daniel J. DeAngelo. Their work appears in journals such as Blood, HemaSphere, Nature Communications, Leukemia and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.